| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |